Filing Details

Accession Number:
0001209191-16-095084
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-02 21:11:43
Reporting Period:
2016-01-29
Filing Date:
2016-02-02
Accepted Time:
2016-02-02 21:11:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326732 Xencor Inc XNCR Pharmaceutical Preparations (2834) 201622502
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1218981 Iii S John Stafford 350 N. Orleans, 2N
Chicago IL 60654
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-01-29 25 $10.83 25 No 4 P Indirect By Limited Liability Company
Common Stock Disposition 2016-02-01 25 $10.79 0 No 4 S Indirect By Limited Liability Company
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Limited Liability Company
No 4 S Indirect By Limited Liability Company
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,264,740 Direct
Footnotes
  1. The Reporting Person's purchase of the Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 25 shares, with the Reporting Person's sale of 30,000 shares of the Issuer's common stock at a weighted average price of $15.1302 per share on December 3, 2015. The Reporting Person has agreed to pay to the Issuer, upon settlement of the purchase, $107.50, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
  2. These securities are held of record by Ronin Capital, LLC, a limited liability company owned and managed by the Reporting Person. The Reporting Person is the indirect beneficial owner of all the shares of common stock of Xencor, Inc. held of record by Ronin Capital, LLC.